High Grade Astrocytic Tumor — Trials

High Grade Astrocytic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

1,778 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 495
Recruiting: 263
Ph III recruiting: 15
Growth YoY: +41.8%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 201–250 of 1,778 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06805305	DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)	recruiting	Phase 2	180	Diakonos Oncology CorporationINDUSTRY	1	Jul 1, 2026	clinicaltrials
NCT07674095	Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma	active not recruiting	—	150	BPGbioINDUSTRY	1	Jul 1, 2026	clinicaltrials